ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "health status"

  • Abstract Number: 1538 • ACR Convergence 2024

    Patient Reported Outcomes Analyses from AURORA 1 Clinical Trial: Lupus Impact Tracker and LupusPRO

    Meenakshi Jolly1, Matt Truman2, Ronald Flauto3 and Kathryn Dao4, 1Rush University, Chicago, IL, 2Aurinia Pharmaceuticals, Victoria, BC, Canada, 3Aurinia Pharmaceuticals, Rockville, MD, 4Rheum101, Rockville, MD

    Background/Purpose: Voclosporin used in addition to Mycophenolate Mofetil and low dose oral steroids in patients with active Lupus Nephritis (LN) was found to be superior…
  • Abstract Number: 0123 • ACR Convergence 2024

    The Impact of Sedentary Behavior and Physical Activity Level on Clinical Parameters and Quality of Life in Patients with Primary Antiphospholipid Syndrome (PAPS)

    Carla Silva1 and Danieli Andrade2, 1University of Sao Paulo, Salvador, Bahia, Brazil, 2University of São Paulo, São Paulo, SP, Brazil

    Background/Purpose: PAPS is an autoimmune disease marked by thrombosis, obstetric poor outcomes and antiphospholipid antibodies. Despite treatment, APS is associated with high morbidity and mortality,…
  • Abstract Number: 0261 • ACR Convergence 2024

    Clinical Implications, Bacterial Profiles, and Patient Outcomes in Hospitalized Patients with Autoimmune Rheumatic Diseases

    Angel Kevin Garza-Elizondo1, Ana Cecilia Bardan-Inchaustegui2, Pablo Gamez-Siller3, Diana Elsa Flores-Alvarado4, Jorge Esquivel-Valerio5, Jesus Cardenas-de la Garza2, Elsa Catalina Davila-Correa6, Alejandra Jacquelin Osuna-Corrales6, Karla Judith Duran-Villarreal6, Daniela Alejandra Salcedo-Soto7, Derek de Jesus Gauna-Leal6, Andrea Axelle Prado-Prado6, Debanhi Morales-Espronceda6, Nathalia Valdez-Benavides6, Nirvana Amairany González-Ontiveros6 and Dionicio Galarza-Delgado8, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, San Nicolás de los Garza, Mexico, 2Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 3Facultad de Medicina UANL, Monterrey, Nuevo León, Mexico, 4Hospital Universitario Jose Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico, 5Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, MONTERREY, Mexico, 6Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Mexico, 7Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey, Mexico, 8UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Autoimmune rheumatic diseases (ARD) are chronic conditions that affect multiple organ systems. Patients with ARD tend to have a weak immune system due to…
  • Abstract Number: 0548 • ACR Convergence 2024

    Associations and Impact of Kinesiophobia on Patient Reported Outcomes and Performance-based Mobility Measures in Patients with Axial Spondyloarthritis

    David Kiefer1, Juergen Braun2, Uta Kiltz3, Niklas Kolle1, Lucia Schneider1, Ioana Andreica4, Bjoern Buehring5, Philipp Sewerin6, Imke Redeker7, Styliani Tsiami8, Susanne Herbold9 and Xenofon Baraliakos8, 1Ruhr-Universität Bochum; Rheumazentrum Ruhrgebiet, Herne, Germany, 2Rheuma Praxis, Ruhr-University Bochum, Berlin, Germany, 3Rheumazentrum Ruhrgebiet Herne, Ruhr-University, D-44649 Herne, Germany, 4Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 5Bergisches Rheuma-Zentrum Wuppertal; Ruhr-Universität Bochum, Wuppertal, Germany, 6Ruhr-Universität Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany, 7Ruhr Universität Bochum, Bochum, Germany, 8Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 9Rheumazentrum Ruhrgebiet, Herne, Herne, Germany

    Background/Purpose: Kinesiophobia, defined as the fear of movement, poses a significant barrier to effective rehabilitation, functional recovery, and adequate physical activity. To investigate the impact…
  • Abstract Number: 0661 • ACR Convergence 2024

    Validity, Reliability and Responsiveness of Lupus Impact Tracker and LupusPRO: AURORA Trial

    Meenakshi Jolly1, Matt Truman2, Ronald Flauto3 and Kathryn Dao4, and AURORA, 1Rush University Medical Center, Chicago, 2Aurinia Pharmaceuticals, Victoria, BC, Canada, 3Aurinia Pharmaceuticals, Rockville, MD, 4Aurinia Pharmaceuticals, Dallas

    Background/Purpose: Voclosporin used in addition to Mycophenolate Mofetil and low dose oral steroids in patients with active Lupus Nephritis (LN) was found to be superior…
  • Abstract Number: 1048 • ACR Convergence 2024

    Self-Perception of Oral Health and Habits in Patients with Sjögren’s Syndrome, Rheumatoid Arthritis, and Systemic Lupus Erythematosus

    Karina Palomo-Arnaud1, Gabriel Figueroa-Parra2, Angel Kevin Garza-Elizondo1, Margarita Isabel Alarcon Jarquin3, Jesus Cardenas-de la Garza4, Dionicio Galarza-Delgado5 and Janett Riega Torres2, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, San Nicolás de los Garza, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 3Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico, 4Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 5UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Oral manifestations, especially periodontitis and tooth loss, are highly prevalent in patients with rheumatic diseases. Sjogren’s syndrome (SS), rheumatoid arthritis (RA), and systemic lupus…
  • Abstract Number: 1253 • ACR Convergence 2024

    Patterns of Patient-reported Outcome Measures in Patients with Systemic Lupus Erythematosus with or Without Concurrent Fibromyalgia

    Heather Gold1, Yi Li1, Rebecca Anthopolos1, Peter Izmirly2, Jill Buyon1, Mala Masson3, Brooke Cohen1, Kamil Barbour4, Amit Saxena5, H Michael Belmont5, Chung-E Tseng6 and Kelly Corbitt7, 1NYU Grossman School of Medicine, New York, NY, 2New York University Grossman School of Medicine, New York, NY, 3NYU Langone Medical Center- Division of Rheumatology, New York, NY, 4CDC, Alpharetta, GA, 5NYU School of Medicine, New York, NY, 6NYU Langone Health, Flushing, NY, 7University of Miami Miller School of Medicine, El Portal, FL

    Background/Purpose: Patients with SLE often have concomitant FM or symptoms similar to FM, including chronic pain, fatigue, sleep disturbance, and/or depression, potentially distinct from immune-mediated…
  • Abstract Number: 1339 • ACR Convergence 2024

    When Medications Fail: A Mixed Methods Study Evaluating the Experience and Health-Related Quality of Life (HRQOL) of Adults with Rheumatoid Arthritis Non-Responsive to Treatment

    Kathleen Carluzzo1, Erin Knight1, Sidney May1, Laura Bernstein2, Kristen Mueller3, Clifton Bingham4 and Karen Schifferdecker1, 1Dartmouth College, Lebanon, NH, 2Dartmouth College, Philadelphia, PA, 3Arthritis Foundation, Washington, DC, 4Johns Hopkins University, Baltimore, MD

    Background/Purpose: RA treatment involves an iterative approach to identifying effective medications for patients. While response varies, there is little in-depth understanding of patients’ perspectives of…
  • Abstract Number: 1403 • ACR Convergence 2024

    Development, Validation and Clinical Use of Health-Related Behaviour Health Fitness Questionnaire (HR-BHF) in Indian (Asian) Subjects Attending a Community Rheumatology Center

    MANJIT SALUJA1 and ARVIND CHOPRA2, 1CENTER FOR RHEUMATIC DISESAES, Pune, Maharashtra, India, 2CENTER FOR RHEUMATIC DISEASES, Pune, Maharashtra, India

    Background/Purpose: Our patients often express concerns related to ‘wellbeing’ that are not routinely attended during  standard care (including QOL). Alternatively, these concerns are important components…
  • Abstract Number: 0762 • ACR Convergence 2023

    Liver Disease Is a Common Feature of HA20 That Causes Significant Morbidity Associated with Interferon Induction

    Magdalena Harasimowicz1, Deborah Stone2, Manuel Carpio Tumba1, Tina Romeo2, Urekha Karri1, Patrycja Hoffmann3, Helen Leavis4, Alexander Miethke5, Theo Heller2, Anjali Rai2, Ivona Aksentijevich2, amanda ombrello6, Daniel Kastner7 and Daniella Schwartz1, 1University of Pittsburgh, Pittsburgh, PA, 2NIH, Bethesda, MD, 3NIH, Vienna, VA, 4Infection Immunity Utrecht, Utrecht, Netherlands, 5Cincinnati Children's Hospital, Cincinnati, OH, 6National Institutes of Health, Rockville, MD, 7National Human Genome Research Institute, Bethesda, MD

    Background/Purpose: Heterozygous loss-of-function TNFAIP3 mutations cause A20 haploinsufficiency (HA20), an early-onset immune dysregulatory disease1. While HA20 was initially described as an inherited form of Behcet’s…
  • Abstract Number: 0824 • ACR Convergence 2023

    Defining Poor Global Functioning and Health in Axial Spondyloarthritis, Using the EQ-5D-3L Questionnaire, When the ASAS-Health Index Is Not Available Is Feasible. an Analysis of 2651 Patients from the PERSPA Study

    Juliette Drouet1, Clementina López Medina2, Anna Molto3, Benjamin Granger1, Bruno Fautrel4, Cécile Gaujoux Viala5, Uta Kiltz6, Maxime Dougados7 and Laure Gossec8, 1Sorbonne Université, INSERM, and Pitié Salpêtrière Hospital, Paris, France, 2Rheumatology Department, Cochin Hospital; INSERM (U1153): Clinical Epidemiology and Biostatistics, University of Paris; Rheumatology Department, Reina Sofia Hospital, Cordoba / IMIBIC / University of Cordoba, Cordoba, Spain, 3HOPITAL COCHIN AP-HP, Service de Rhumatologie, Paris, France, 4Sorbonne Université APHP, Paris, France, 5IDESP Univ Montpellier, INSERM, Rheumatology, CHU Nîmes, Montpellier, France, 6Rheumazentrum Ruhrgebiet, Herne, Germany, 7Rheumatology Department, Cochin Hospital; INSERM (U1153): Clinical Epidemiology and Biostatistics, University of Paris, Paris, France, 8Sorbonne Université and Pitié Salpêtrière Hospital, Paris, France

    Background/Purpose: In axial Spondyloarthritis (axSpA) it is recommended to assess global functioning and health, a concept close to health-related quality of life (HR-QoL), using the…
  • Abstract Number: 1275 • ACR Convergence 2023

    Prevalence of Frailty Among Individuals Living with Rheumatoid Arthritis: A Population-based Cohort Study

    Alexandra Legge1 and Diane Lacaille2, 1Dalhousie University, Halifax, NS, Canada, 2Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Studies have demonstrated a link between frailty and chronic inflammation, raising the question of whether chronic inflammatory diseases like rheumatoid arthritis (RA) may be…
  • Abstract Number: 1480 • ACR Convergence 2023

    Demographic and Clinical Characteristics of Patients with LN: A Multicenter Study from the Gulf Region

    Jamal Al-Saleh1, Faisal Elbadawi1, Rajaie Namas2, Samar Al-Emadi3, Khalid A. Alnaqbi4, Humaid A. Al-Wahshi5, Amjad Alkadi6, Suad Hannawi7, Mohamed Hamouda8, Averyan Vasylyev8, Arwa Al-Shujairi8, Reem Al-Jayyousi9 and Munther Khamashta8, 1Dubai Hospital, Department of Rheumatology, Dubai, United Arab Emirates, 2Cleveland Clinic Abu Dhabi, Department of Rheumatology, Abu Dhabi, United Arab Emirates, 3Hamad Medical Corporation, Department of Rheumatology, Doha, Qatar, 4Tawam Hospital, Department of Rheumatology, Al Ain, United Arab Emirates, 5The Royal Hospital, Department of Rheumatology, Muscat, Oman, 6Ministry of Health, Kuwait, Kuwait, 7Kuwait Hospital, Department of Rheumatology, Dubai, United Arab Emirates, 8GSK Gulf, Medical Affairs Department, Dubai, United Arab Emirates, 9Mohamed Bin Rashid University of Medicine and Health Sciences, College of Medicine, Dubai, United Arab Emirates, and Mediclinic Parkview, Dubai, United Arab Emirates

    Background/Purpose: Data from limited studies of LN in the Gulf region suggest that LN manifests more severely in this region than in Caucasian populations, yet…
  • Abstract Number: 1516 • ACR Convergence 2023

    Systemic Sclerosis Gastrointestinal Tract Vascular Biomarkers of Symptomatic Disease Activity

    Venkateswara Gogulamudi1, Sarah Wood2, Elizabeth Johnson2, Aaron Petrey3, Anthony Donato4 and Tracy Frech2, 1Salt Lake Veterans Affairs Medical Center, Salt Lake City, UT, 2Vanderbilt University Medical Center, Nashville, TN, 3University of Utah, Salt Lake City, UT, 4University of Utah and Salt Lake VAMC, Salt Lake City, UT

    Background/Purpose: Gastrointestinal tract symptoms are common in systemic sclerosis (SSc). The Scleroderma Clinical Trials Consortium University of California Los Angeles Gastrointestinal Tract Questionnaire (GIT 2.0)…
  • Abstract Number: 2194 • ACR Convergence 2023

    Association of Self-perceived Oral Health Status with ESSPRI Reported by Sjögren’s Syndrome Patients

    Oscar E. Alvarez-González1, Hector Guerra2, Elena A. Quintana-Aguilar2, Sandra P. Arroyo-Sánchez2, Jesus S. Cortez-Gutierrez2, Jesus Alberto Cardenas-De la Garza3, Francisco J. Torres-Quintanilla4, Janett Riega-Torres5, Cassandra Michele Skinner-Taylor5 and Dionicio A. Galarza-Delgado6, 1Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 3Hospital Universitario "Dr. José Eleuterio González", San Nicolas, Mexico, 4Hospital Universitario "Dr. José Eleuterio González", UANL, Monterrey, Mexico, 5Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 6Hospital Universitario UANL, Monterrey, Mexico

    Background/Purpose: Salivary gland hypofunction, manifested as xerostomia in Sjögren's syndrome (SS), causes dental, language, and nutritional problems, leading to a detriment in oral health. The…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology